Related Experiment Video
Updated: Feb 3, 2026

Quantification of γH2AX Foci in Response to Ionising Radiation
Published on: April 6, 2010
The DNA damage response in immunotherapy and radiation
Robert M Samstein1, Nadeem Riaz1
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Purpose:
Deficiencies in DNA damage repair (DDR) and response represent a common alteration in tumors, and exploitation of this feature using therapeutics has become more prominent.
Methods And Materials:
Recent work has highlighted the important interaction between DDR defects, as well as DDR targeting agents such as radiation and the immunogenicity of the tumor. This relationship emphasizes the potential for combination therapeutics with immune checkpoint inhibitors (ICI). Somatic mutations and DDR defects are some of the strongest predictors of response to ICI.
Results:
This review highlights the interplay among DDR pathways, ionizing radiation, and ICI efficacy. The mechanisms of radiation immunogenicity, including the cytosolic DNA sensing cGAS/STING pathways, are also described.
Conclusions:
A greater mechanistic understanding of the complex interaction between the DNA damage response and the immune system will expand the therapeutic potential of immunotherapy for patients with advanced cancer.
Insights
Exploiting DNA damage repair (DDR) defects in tumors with therapies like radiation can enhance anti-tumor immunity. Combining DDR targeting agents with immune checkpoint inhibitors (ICI) shows promise for advanced cancer treatment.
Area of Science:
- Oncology
- Cancer Immunology
- Molecular Biology
Background:
- Deficiencies in DNA damage repair (DDR) are common in tumors.
- Targeting DDR defects therapeutically is an emerging strategy.
- DDR defects influence tumor immunogenicity and response to immunotherapy.
Purpose of the Study:
- To review the interplay between DDR pathways, radiation, and immune checkpoint inhibitor (ICI) efficacy.
- To describe mechanisms of radiation-induced immunogenicity.
- To highlight the potential of combination therapies.
Main Methods:
- Literature review of studies on DDR, radiation, and immunotherapy.
- Analysis of mechanisms linking DDR defects to immune responses.
- Discussion of clinical implications for combination therapeutics.
Main Results:
- DDR defects and ionizing radiation can enhance tumor immunogenicity.
- Cytosolic DNA sensing pathways, such as cGAS/STING, mediate radiation-induced immune responses.
- Somatic mutations and DDR defects predict response to ICI.
Conclusions:
- Understanding the DDR-immune system interaction is crucial for advancing cancer immunotherapy.
- Combination of DDR targeting agents with ICI offers a promising therapeutic avenue for advanced cancers.
- Further research into these mechanisms will expand immunotherapy's potential.
More Related Videos
Related Concept Videos
Biological Effects of Radiation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Tumor Immunotherapy
Overview of DNA Repair
Chemically...
Radiation: Applications
The average...

